Pieris Pharmaceuticals Inc (NASDAQ:PIRS) is trading slightly higher in the pre-market session after the news.
PIRS stock is trading up by 1.06% at $1.90 with just 202 shares traded.
PIRS Issues News
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
- Net loss was $4.2 million or $(0.07) per share for the quarter ended March 31, 2021, compared to a net loss of $3.6 million or $(0.07) per share for the quarter ended March 31, 2020.
- Cash and cash equivalents totaled $66.8 million for the quarter ended March 31, 2021, compared to a cash and cash equivalents balance of $70.4 million for the quarter ended December 31, 2020.
- R&D expenses were $16.6 million for the quarter ended March 31, 2021, compared to $12.8 million for the quarter ended March 31, 2020.
|SHARES OUTSTANDING||173.61 M|
|SHARE FLOAT (%)||88.45 M (50.95%)|
|% HELD BY INSTITUTIONS||7.76|
Recent Stock Performance
|+/- EMA(20)||2.12 (-1.42%)|
|+/- SMA(50)||2.15 (-2.79%)|
|+/- SMA(200)||1.46 (+43.15%)|
|CCI20||-86.7407||Sell||Chaikin Money Flow||-0.1820||Sell|
|MACD||-0.0619||Sell||Money Flow Index||50.9062||Buy|
|STOCH (14,3)||18.3636||OverSold||STOCH RSI||0.3312||Neutral|